The Journal of pediatrics
-
The Journal of pediatrics · Dec 2005
Randomized Controlled Trial Multicenter StudyNoninvasive therapy with helium-oxygen for severe bronchiolitis.
To determine whether noninvasive therapy using a helium-oxygen mixture reduces the use of positive-pressure ventilation in the treatment of respiratory failure caused by severe bronchiolitis. ⋯ This study did not detect any differences between the patients in the helium group and the control group with respect to the rate of positive-pressure ventilation.
-
The Journal of pediatrics · Dec 2005
Review Case ReportsEfficacy of bystander cardiopulmonary resuscitation and out-of-hospital automated external defibrillation as life-saving therapy in commotio cordis.
We report a child who sustained commotio cordis after being struck by a baseball, and offer documentation of the advantages of having readily available access to bystander cardiopulmonary resuscitation (CPR) and an automated external defibrillator (AED). We suggest that communities and school districts reexamine the need for accessible AEDs and CPR-trained coaches at organized sporting events for children.
-
The Journal of pediatrics · Dec 2005
Multicenter StudyPotential medication dosing errors in outpatient pediatrics.
To determine the prevalence of potential dosing errors of medication dispensed to children for 22 common medications. ⋯ Potential medication dosing errors occur frequently in outpatient pediatrics. Studies on the clinical impact of these potential errors and effective error prevention strategies are needed.
-
The Journal of pediatrics · Dec 2005
Case ReportsSpontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: a potential role for recombinant factor VIIa.
Necrotizing enterocolitis remains a serious condition in very low birth weight infants, particularly in those infants who require surgery. Perioperative hemorrhage is a potentially fatal complication in this population. We describe our experience in 4 premature infants with necrotizing enterocolitis who received recombinant factor VIIa to manage life-threatening intraoperative hemorrhage.